603882 金域医学
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额43,4301,202,009906,3481,230,8211,947,843
投资活动产生之现金流量净额(136,330)(370,972)(455,529)(634,534)(848,369)
筹资活动产生之现金流量净额(411,604)(394,203)(488,801)(1,062,016)(868,567)
汇率变动对现金及现金等价物的影响11,117(13,551)10,8327,38738,949
现金及现金等价物净增加/(减少)(493,386)423,283(27,150)(458,343)269,856
期初现金及现金等价物余额2,845,8072,422,5252,449,6742,908,0172,638,161
期末现金及现金等价物余额2,352,4212,845,8082,422,5252,449,6742,908,017